Literature DB >> 27994745

Characterization of the Dynamic Equilibrium between Closed and Open Forms of the Benzoxaborole Pharmacophore.

Sergey Vshyvenko1, Marissa L Clapson1, Itaru Suzuki1, Dennis G Hall1.   

Abstract

Benzoxaboroles are a class of five-membered hemiboronic acids that recently attracted significant attention as a new pharmacophore on account of their unique structural and physicochemical properties and their ability to interact selectively with biomolecules. Their structural behavior in water and its effect on their physiological properties remain unclear, especially the question of dynamic hydrolytic equilibrium of the oxaborole ring. Herein, we used NMR spectroscopy, in mixed aqueous-organic solvent, to confirm the strong preference for the closed form of benzoxaborole and its six- and seven-membered homologues over the open boronic acid form. Only with the eight-membered homologue does the cyclic form become unfavorable. Using dynamic VT-NMR studies with designed probe compound 20, we demonstrate that the oxaborole ring undergoes rapid hydrolytic ring closing-opening at ambient temperature at a rate of >100 Hz via a mechanism featuring rate-limiting proton-transfer steps. This knowledge can help provide a better understanding of the behavior of benzoxaboroles in biological systems.

Entities:  

Keywords:  Benzoxaborole; VT-NMR; boron heterocycles; hydrolysis; ring size

Year:  2016        PMID: 27994745      PMCID: PMC5151146          DOI: 10.1021/acsmedchemlett.6b00300

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  10 in total

1.  Intra/intermolecular direct allylic alkylation via Pd(II)-catalyzed allylic C-H activation.

Authors:  Song Lin; Chun-Xiao Song; Gui-Xin Cai; Wen-Hua Wang; Zhang-Jie Shi
Journal:  J Am Chem Soc       Date:  2008-09-09       Impact factor: 15.419

2.  Recent developments in the chemistry and biological applications of benzoxaboroles.

Authors:  Agnieszka Adamczyk-Woźniak; Krzysztof M Borys; Andrzej Sporzyński
Journal:  Chem Rev       Date:  2015-05-27       Impact factor: 60.622

Review 3.  The unique chemistry of benzoxaboroles: current and emerging applications in biotechnology and therapeutic treatments.

Authors:  C Tony Liu; John W Tomsho; Stephen J Benkovic
Journal:  Bioorg Med Chem       Date:  2014-05-10       Impact factor: 3.641

4.  Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis.

Authors:  Robert T Jacobs; Jacob J Plattner; Bakela Nare; Stephen A Wring; Daitao Chen; Yvonne Freund; Eric G Gaukel; Matthew D Orr; Joe B Perales; Matthew Jenks; Robert A Noe; Jessica M Sligar; Yong-Kang Zhang; Cyrus J Bacchi; Nigel Yarlett; Robert Don
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

5.  Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis.

Authors:  Stephen J Baker; Yong-Kang Zhang; Tsutomu Akama; Agnes Lau; Huchen Zhou; Vincent Hernandez; Weimin Mao; M R K Alley; Virginia Sanders; Jacob J Plattner
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

Review 6.  Boron-containing inhibitors of synthetases.

Authors:  Stephen J Baker; John W Tomsho; Stephen J Benkovic
Journal:  Chem Soc Rev       Date:  2011-02-07       Impact factor: 54.564

7.  Orthogonal reactivity in boryl-substituted organotrifluoroborates.

Authors:  Gary A Molander; Deidre L Sandrock
Journal:  J Am Chem Soc       Date:  2008-11-26       Impact factor: 15.419

8.  A facile one-pot preparation of potassium hydroxyaryl- and (hydroxyalkyl)aryltrifluoroborates.

Authors:  Young Hee Park; Hong Ryul Ahn; Belgin Canturk; Sang Il Jeon; Seokjoon Lee; Heonjoong Kang; Gary A Molander; Jungyeob Ham
Journal:  Org Lett       Date:  2008-02-23       Impact factor: 6.005

9.  Universal reaction mechanism of boronic acids with diols in aqueous solution: kinetics and the basic concept of a conditional formation constant.

Authors:  Yuki Furikado; Tomomi Nagahata; Takuya Okamoto; Tomoaki Sugaya; Satoshi Iwatsuki; Masahiko Inamo; Hideo D Takagi; Akira Odani; Koji Ishihara
Journal:  Chemistry       Date:  2014-08-28       Impact factor: 5.236

10.  Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis.

Authors:  Tsutomu Akama; Stephen J Baker; Yong-Kang Zhang; Vincent Hernandez; Huchen Zhou; Virginia Sanders; Yvonne Freund; Richard Kimura; Kirk R Maples; Jacob J Plattner
Journal:  Bioorg Med Chem Lett       Date:  2009-03-09       Impact factor: 2.823

  10 in total
  4 in total

Review 1.  Boron Chemicals in Drug Discovery and Development: Synthesis and Medicinal Perspective.

Authors:  Bhaskar C Das; Nitesh K Nandwana; Sasmita Das; Varsha Nandwana; Mohammed Adil Shareef; Yogarupa Das; Mariko Saito; Louis M Weiss; Frankis Almaguel; Narayan S Hosmane; Todd Evans
Journal:  Molecules       Date:  2022-04-19       Impact factor: 4.927

2.  Cyclic Boronates Inhibit All Classes of β-Lactamases.

Authors:  Samuel T Cahill; Ricky Cain; David Y Wang; Christopher T Lohans; David W Wareham; Henry P Oswin; Jabril Mohammed; James Spencer; Colin W G Fishwick; Michael A McDonough; Christopher J Schofield; Jürgen Brem
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents.

Authors:  Paolo Saul Coghi; Yinghuai Zhu; Hongming Xie; Narayan S Hosmane; Yingjun Zhang
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

4.  High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes.

Authors:  Hector Newman; Alen Krajnc; Dom Bellini; Charles J Eyermann; Grant A Boyle; Neil G Paterson; Katherine E McAuley; Robert Lesniak; Mukesh Gangar; Frank von Delft; Jürgen Brem; Kelly Chibale; Christopher J Schofield; Christopher G Dowson
Journal:  J Med Chem       Date:  2021-07-31       Impact factor: 8.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.